NCT02260947View on ClinicalTrials.gov

Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DRUG

PF-06273340

PF-06273340 50 mg

DRUG

PF-06273340

PF-06273340 400 mg

DRUG

Pregabalin

Pregabalin 300 mg

DRUG

Ibuprofen

Ibuprofen 600 mg

DRUG

Placebo

Matching Placebo

Trial Locations (1)

2333

Centre for Human Drug Research, Leiden

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02260947 - Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints | Biotech Hunter | Biotech Hunter